All stocks Β· KIMIABL
KB

KIMIA BIOSCIENCES LIMITED

KIMIABL BSE Drug Manufacturers - Specialty & Generic Healthcare

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hyperten…

ISIN INE285U01025
Listed β€”
Quarters tracked 13
Filings 19 docs

About

Kimia Biosciences Limited manufactures and sells active pharmaceutical ingredients (APIs) in India. The company offers and develops APIs in the categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, lipid lowering agents, vitamin, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, and anti-bacterial, as well as anti-psychotic, anti-fungal, urologicals, anti-inflammatory, prokinetic agent, cholelithiasis agent, anti-asthmatic, anti-depressant, anti-acne, decongestant, and anti-virals. It exports its products. Kimia Biosciences Limited was formerly known as Laurel Organics Ltd and changed its name to Kimia Biosciences Limited January 2019. The company was incorporated in 1993 and is based in New Delhi, India.

Key Metrics

as of Sep 2026
Market Cap143 Cr
P/E19.90
Div Yield0.00 %
Book Valueβ‚Ή3.75
52w Highβ‚Ή43.30
52w Lowβ‚Ή23.20
Face Valueβ‚Ή1.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 20.72 27.20 30.10 34.00 23.58 38.24 30.10 28.18 22.40 30.30 26.14 24.20 24.23
Expenses 18.37 24.54 23.54 31.48 21.05 30.06 25.10 24.81 18.69 26.14 27.19 26.16 25.87
Operating Profit 2.35 2.66 6.56 2.52 2.53 8.18 5.00 3.37 3.71 4.16 -1.05 -1.96 -1.64
OPM % 11.34 9.78 21.79 7.41 10.73 21.39 16.61 11.96 16.56 13.73 -4.02 -8.10 -6.77
Other Income 0.08 1.01 0.10 -0.33 0.85 0.44 0.42 0.37 0.08 0.30 0.58 0.64 0.13
Depreciation 1.11 1.16 0.85 0.97 0.94 0.88 0.82 0.79 0.90 0.82 0.82 0.82 0.83
Interest 0.83 0.75 0.75 0.27 1.75 1.40 1.01 1.04 1.11 1.34 1.31 1.12 1.28
Profit before tax 0.49 1.76 5.06 0.95 0.69 6.34 3.59 1.91 1.78 2.30 -2.60 -3.26 -3.62
Tax % 26.53 78.98 -7.71 -7.37 13.04 68.61 -27.30 15.71 19.66 22.17 -25.00 -25.15 -25.14
Net Profit 0.36 0.37 5.44 1.02 0.60 1.99 4.57 1.61 1.44 1.80 -1.95 -2.44 -2.71
EPS in Rs 0.08 0.08 1.15 0.22 0.13 0.42 0.97 0.34 0.30 0.38 -0.41 -0.52 -0.57

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 115.00119.00105.00129.00125.00133.00106.0094.0076.001.000.002.00
Expenses 101.0099.00105.00133.00124.00124.00102.0088.0074.002.004.004.00
Operating Profit 14.0020.000.00-5.001.008.004.006.002.00-1.00-3.00-2.00
OPM % 12.0017.00-0.50-3.900.506.004.206.003.20-56.00-1,779.00-110.00
Other Income 2.001.002.000.001.002.001.001.001.000.000.001.00
Interest 4.005.005.004.004.003.003.002.001.000.001.000.00
Depreciation 4.003.003.003.003.002.002.001.001.000.000.000.00
Profit before tax 8.0014.00-7.00-12.00-5.006.001.004.002.00-1.00-4.00-2.00
Tax % 12.0029.00-26.00-25.00-26.008.00-13.00-1.00-4.00-8.000.001.00
Net Profit 7.0010.00-5.00-9.00-4.005.001.004.002.00-1.00-4.00-2.00
EPS in Rs 1.572.03-1.12-1.98-0.781.080.302.642.26-1.26-5.48-2.30
Dividend Payout % 0.000.000.000.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 5.005.005.005.005.005.005.001.001.007.007.007.00
Reserves 13.005.00-4.001.0010.0014.009.004.000.00-12.00-11.00-7.00
Borrowings 35.0033.0044.0053.0041.0045.0034.0031.0034.0014.007.001.00
Other Liabilities 51.0068.0056.0063.0054.0043.0038.0029.0022.003.001.004.00
Total Liabilities 103.00111.00100.00121.00109.00107.0086.0065.0058.0012.004.005.00
Fixed Assets 37.0033.0032.0034.0035.0028.0018.0016.0013.007.003.003.00
CWIP 0.000.001.001.000.006.006.002.002.003.000.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 66.0078.0068.0087.0074.0072.0062.0048.0043.002.001.001.00
Total Assets 103.00111.00100.00121.00109.00107.0086.0065.0058.0012.004.005.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 11.0021.0015.00-7.008.006.000.00-3.00-7.00-1.00-6.000.00
Cash from Investing Activity -8.00-5.00-1.00-3.00-1.00-14.00-9.00-2.00-2.00-6.000.000.00
Cash from Financing Activity -3.00-17.00-13.0010.00-8.008.008.004.0010.007.006.000.00
Net Cash Flow 0.000.000.000.000.000.000.000.000.000.000.000.00
Free Cash Flow 3.0017.0013.00-10.006.00-8.00-9.00-5.00-10.00-7.00-6.000.00
CFO/OP % 76.00105.00-3,021.00136.001,281.0071.005.00-45.00-287.0085.00177.00-2.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 93.00113.0096.0087.0088.00115.00128.00113.00141.0020.00173.0056.00
Inventory Days 137.00178.00149.00183.00146.0089.0092.0083.0059.00615.00319.0050.00
Days Payable 220.00260.00194.00177.00159.00116.00121.0091.00120.00511.0091.00667.00
Cash Conversion Cycle 10.0031.0051.0093.0076.0088.00100.00105.0080.00124.00401.00-560.00
Working Capital Days 5.00-22.00-30.0016.0031.0053.0073.0062.0048.00-1,358.00-173.00-530.00
ROCE % 25.0042.00-4.00-12.00-2.0016.009.0016.0010.00-10.00-188.00-127.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94
DIIs 0.38 0.38 0.38 0.38 0.38 0.38 0.38 0.38 0.38 0.38 0.38 0.38
Public 24.68 24.68 24.68 24.68 24.68 24.67 24.68 24.67 24.68 24.67 24.66 24.67
No. of Shareholders 12,775 12,775 12,751 12,616 12,200 12,278 12,231 12,179 12,023 12,110 12,063 12,118

Corporate Actions

1 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 15 Nov 2018 16 Nov 2018 β€” β€” Reduction of Capital

Announcements

5 filings